{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:44:51Z","timestamp":1793850291328,"version":"4.6.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000098","name":"National Institutes of Health Clinical Center","doi-asserted-by":"publisher","award":["R01NS102451"],"award-info":[{"award-number":["R01NS102451"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS116400"],"award-info":[{"award-number":["R01NS116400"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS114218"],"award-info":[{"award-number":["R01NS114218"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RF-2019-12370334"],"award-info":[{"award-number":["RF-2019-12370334"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["PNRR-POC-2023-12,377,653"],"award-info":[{"award-number":["PNRR-POC-2023-12,377,653"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE0000006"],"award-info":[{"award-number":["PE0000006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017336","name":"Dipartimenti di Eccellenza","doi-asserted-by":"publisher","award":["2023-2027"],"award-info":[{"award-number":["2023-2027"]}],"id":[{"id":"10.13039\/100017336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nbd.2025.107046","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:55:12Z","timestamp":1753977312000},"page":"107046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nusinersen corrects L-arginine deficiency in the cerebrospinal fluid of patients with severe spinal muscular atrophy"],"prefix":"10.1016","volume":"214","author":[{"given":"Amber","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"di Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Caretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Panicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vercelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Boido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Pellizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107046_bb0005","first-page":"65","article-title":"Evaluation of the therapeutic efficacy and tolerability of current drug treatments on the clinical outcomes of paediatric spinal muscular atrophy type 1: a systematic review","volume":"48","author":"Al-Taie","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0010","article-title":"Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy","volume":"94","author":"Alves","year":"2020"},{"key":"10.1016\/j.nbd.2025.107046_bb0015","first-page":"17472","article-title":"Discovery of a CNS penetrant small molecule SMN2 splicing modulator with improved tolerability for spinal muscular atrophy","volume":"10","author":"Ando","year":"2020"},{"key":"10.1016\/j.nbd.2025.107046_bb0020","first-page":"5587","article-title":"Revisiting glutamate excitotoxicity in amyotrophic lateral sclerosis and age-related neurodegeneration","volume":"25","author":"Arnold","year":"2024"},{"key":"10.1016\/j.nbd.2025.107046_bb0025","first-page":"953","article-title":"Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse","volume":"28","author":"Biondi","year":"2008"},{"key":"10.1016\/j.nbd.2025.107046_bb0030","first-page":"11288","article-title":"In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons, and enhances SMN2 gene expression in severe spinal muscular atrophy mice","volume":"30","author":"Biondi","year":"2010"},{"key":"10.1016\/j.nbd.2025.107046_bb0035","first-page":"5907","article-title":"Physical exercise reduces cardiac defects in type 2 spinal muscular atrophy-like mice","volume":"590","author":"Biondi","year":"2012"},{"key":"10.1016\/j.nbd.2025.107046_bb0040","article-title":"Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy","volume":"13","author":"Boyd","year":"2017"},{"key":"10.1016\/j.nbd.2025.107046_bb0045","first-page":"4280","article-title":"Shift from extracellular signal-regulated kinase to AKT\/cAMP response element-binding protein pathway increases survival-motor-neuron expression in spinal-muscular-atrophy-like mice and patient cells","volume":"33","author":"Branchu","year":"2013"},{"key":"10.1016\/j.nbd.2025.107046_bb0050","first-page":"3877","article-title":"The role of survival motor neuron protein (SMN) in protein homeostasis","volume":"75","author":"Chaytow","year":"2018"},{"key":"10.1016\/j.nbd.2025.107046_bb0055","article-title":"Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine","volume":"2","author":"Chaytow","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0060","first-page":"476","article-title":"Roles of NMDA receptor activity and nitric oxide production in brain development","volume":"32","author":"Contestabile","year":"2000"},{"key":"10.1016\/j.nbd.2025.107046_bb0065","first-page":"2147","article-title":"Brain nitric oxide and its dual role in neurodegeneration\/neuroprotection: understanding molecular mechanisms to devise drug approaches","volume":"10","author":"Contestabile","year":"2003"},{"key":"10.1016\/j.nbd.2025.107046_bb0070","first-page":"1","article-title":"Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis","volume":"16","author":"Coratti","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0075","first-page":"2029","article-title":"The influence of early nutrition on brain growth and neurodevelopment in extremely preterm babies: a narrative review","volume":"11","author":"Cormack","year":"2019"},{"key":"10.1016\/j.nbd.2025.107046_bb0080","first-page":"6197","article-title":"The role of amino acids in neurotransmission and fluorescent tools for their detection","volume":"21","author":"Dalangin","year":"2020"},{"key":"10.1016\/j.nbd.2025.107046_bb0085","first-page":"4574","article-title":"Serotonergic dysfunction impairs locomotor coordination in spinal muscular atrophy","volume":"146","author":"Delestr\u00e9e","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0090","first-page":"206","article-title":"Spinal muscular atrophy after nusinersen therapy: improved physiology in pediatric patients with no significant change in urine, serum, and liquor 1H-NMR metabolomes in comparison to an age-matched, healthy cohort","volume":"11","author":"Deutsch","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0095","series-title":"Excitatory amino acids as therapeutic agents: Reversing neurodegenerative trajectory by tackling excitotoxicity","first-page":"1","author":"Dhurandhar","year":"2024"},{"key":"10.1016\/j.nbd.2025.107046_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10072-024-07880-3","article-title":"Excitatory amino acids as therapeutic agents: reversing neurodegenerative trajectory by tackling excitotoxicity","volume":"46","author":"Dhurandhar","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.107046_bb0105","first-page":"205","article-title":"L-arginine depletion improves spinal cord injury via immunomodulation and nitric oxide reduction","volume":"10","author":"Erens","year":"2022"},{"key":"10.1016\/j.nbd.2025.107046_bb0110","first-page":"1431","article-title":"Nusinersen induces disease-severity-specific neurometabolic effects in spinal muscular atrophy","volume":"12","author":"Errico","year":"2022"},{"key":"10.1016\/j.nbd.2025.107046_bb0115","first-page":"905","article-title":"Reduced sensory synaptic excitation impairs motor neuron function via Kv2. 1 in spinal muscular atrophy","volume":"20","author":"Fletcher","year":"2017"},{"key":"10.1016\/j.nbd.2025.107046_bb0120","series-title":"Amino Acids in Human Nutrition and Health","first-page":"427","article-title":"Excitatory amino acids in neurological and neurodegenerative disorders","author":"Flores","year":"2012"},{"key":"10.1016\/j.nbd.2025.107046_bb0125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2025.107046_bb0130","first-page":"1049","article-title":"Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment","volume":"8","author":"Freigang","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0135","first-page":"1952","article-title":"Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington\u2019s disease","volume":"18","author":"Grice","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0140","first-page":"1762","article-title":"Glial-derived arginine, the nitric oxide precursor, protects neurons from NMDA-induced excitotoxicity","volume":"14","author":"Grima","year":"2001"},{"key":"10.1016\/j.nbd.2025.107046_bb0145","first-page":"7615","article-title":"Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse","volume":"25","author":"Grondard","year":"2005"},{"key":"10.1016\/j.nbd.2025.107046_bb0150","first-page":"999","article-title":"Recent progress in gene-targeting therapies for spinal muscular atrophy: promises and challenges","volume":"15","author":"Haque","year":"2024"},{"key":"10.1016\/j.nbd.2025.107046_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106849","article-title":"Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy","volume":"207","author":"Hassan","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107046_bb0160","first-page":"427","article-title":"SMN is required for sensory-motor circuit function in Drosophila","volume":"151","author":"Imlach","year":"2012"},{"key":"10.1016\/j.nbd.2025.107046_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35055104","article-title":"Protein S-nitrosylation: a physiological signal for neuronal nitric oxide","volume":"3","author":"Jaffrey","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2025.107046_bb0170","first-page":"1104","article-title":"Astrocytic urea cycle detoxifies A\u03b2-derived ammonia while impairing memory in Alzheimer\u2019s disease","volume":"34","author":"Ju","year":"2022"},{"key":"10.1016\/j.nbd.2025.107046_bb0175","first-page":"389","article-title":"Protein and amino acid metabolism in the human newborn","volume":"28","author":"Kalhan","year":"2008"},{"key":"10.1016\/j.nbd.2025.107046_bb0180","first-page":"421","article-title":"Creatine metabolism: energy homeostasis, immunity and cancer biology","volume":"16","author":"Kazak","year":"2020"},{"key":"10.1016\/j.nbd.2025.107046_bb0185","article-title":"Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA","volume":"13","author":"Kong","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0190","first-page":"1","article-title":"Neuronal NO synthase in the pathogenesis of metabolic syndrome","volume":"17","author":"Kuznetsova","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0195","first-page":"845","article-title":"SMN\u03947, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005"},{"key":"10.1016\/j.nbd.2025.107046_bb0200","first-page":"558","article-title":"Induction of survival of motor neuron (SMN) protein deficiency in spinal astrocytes by small interfering RNA as an in vitro model of spinal muscular atrophy","volume":"11","author":"Leo","year":"2022"},{"key":"10.1016\/j.nbd.2025.107046_bb0205","first-page":"180","article-title":"An overview of the therapeutic strategies for the treatment of spinal muscular atrophy","volume":"34","author":"Li","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0210","article-title":"Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy","volume":"5","author":"Ling","year":"2010"},{"key":"10.1016\/j.nbd.2025.107046_bb0215","first-page":"12189","article-title":"Spinal muscular atrophy patient-derived motor neurons exhibit hyperexcitability","volume":"5","author":"Liu","year":"2015"},{"key":"10.1016\/j.nbd.2025.107046_bb0220","first-page":"440","article-title":"An SMN-dependent U12 splicing event essential for motor circuit function","volume":"151","author":"Lotti","year":"2012"},{"key":"10.1016\/j.nbd.2025.107046_bb0225","article-title":"Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III","volume":"30","author":"Lu","year":"2024"},{"key":"10.1016\/j.nbd.2025.107046_bb0230","first-page":"230","article-title":"Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience","volume":"18","author":"\u0141usakowska","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0235","first-page":"1254","article-title":"Identification of novel biomarkers of spinal muscular atrophy and therapeutic response by proteomic and metabolomic profiling of human biological fluid samples","volume":"11","author":"Meneri","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0240","first-page":"453","article-title":"Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy","volume":"69","author":"Mentis","year":"2011"},{"key":"10.1016\/j.nbd.2025.107046_bb0245","first-page":"706","article-title":"Spinal muscular atrophy\u2014insights and challenges in the treatment era","volume":"16","author":"Mercuri","year":"2020"},{"key":"10.1016\/j.nbd.2025.107046_bb0250","first-page":"52","article-title":"Spinal muscular atrophy","volume":"8","author":"Mercuri","year":"2022"},{"key":"10.1016\/j.nbd.2025.107046_bb0255","first-page":"949","article-title":"Selective vulnerability of motor neurons and dissociation of pre-and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy","volume":"17","author":"Murray","year":"2008"},{"key":"10.1016\/j.nbd.2025.107046_bb0260","first-page":"299","article-title":"Inhibitory learning and memory in newborn rats influenced by nitric oxide","volume":"71","author":"Myslivecek","year":"1996"},{"key":"10.1016\/j.nbd.2025.107046_bb0265","first-page":"28","article-title":"Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients","volume":"3","author":"Nuzzo","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0270","article-title":"Nutraceuticals for L-arginine: glycine amidinotransferase modulation: an overview","volume":"19","author":"Ostojic","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0275","article-title":"Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy","volume":"44","author":"Pagiazitis","year":"2025"},{"key":"10.1016\/j.nbd.2025.107046_bb0280","first-page":"e696","article-title":"An observational study of functional abilities in infants, children, and adults with type 1 SMA","volume":"91","author":"Pane","year":"2018"},{"key":"10.1016\/j.nbd.2025.107046_bb0285","first-page":"443","article-title":"Nusinersen in type 1 spinal muscular atrophy: twelve-month real-world data","volume":"86","author":"Pane","year":"2019"},{"key":"10.1016\/j.nbd.2025.107046_bb0290","first-page":"97","article-title":"Efficacy of risdiplam in spinal muscular atrophy: a systematic review and meta-analysis","volume":"44","author":"Pascual-Morena","year":"2024"},{"key":"10.1016\/j.nbd.2025.107046_bb0295","series-title":"First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy","first-page":"1","author":"Prat-Ortega","year":"2025"},{"key":"10.1016\/j.nbd.2025.107046_bb0300","first-page":"1297","article-title":"Hyperexcitability precedes motoneuron loss in the Smn2B\/\u2212 mouse model of spinal muscular atrophy","volume":"122","author":"Quinlan","year":"2019"},{"key":"10.1016\/j.nbd.2025.107046_bb0305","first-page":"1","article-title":"Gene-targeting therapeutics for neurological disease: lessons learned from spinal muscular atrophy","volume":"72","author":"Ravi","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0310","first-page":"8","article-title":"Curing SMA: are we there yet?","volume":"30","author":"Reilly","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0315","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1074-7427(03)00004-2","article-title":"Effects of nitric oxide inhibition on avoidance learning in the chick are lateralized and localized","volume":"79","author":"Rickard","year":"2003","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.nbd.2025.107046_bb0320","first-page":"1","article-title":"1 H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy","volume":"16","author":"Saffari","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0325","series-title":"Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids","first-page":"12123","volume":"25","author":"Saffari","year":"2024"},{"key":"10.1016\/j.nbd.2025.107046_bb0330","series-title":"RNase H1 counteracts DNA damage and ameliorates SMN-dependent phenotypes in a <em>Drosophila<\/em> model of Spinal Muscular Atrophy","author":"Scatolini","year":"2025"},{"key":"10.1016\/j.nbd.2025.107046_bb0335","first-page":"611","article-title":"Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy","volume":"145","author":"Schmitt","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0340","first-page":"3885","article-title":"Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy","volume":"29","author":"Simon","year":"2019"},{"key":"10.1016\/j.nbd.2025.107046_bb0345","series-title":"Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy","author":"Simon","year":"2025"},{"key":"10.1016\/j.nbd.2025.107046_bb0350","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1126\/science.1353273","article-title":"Nitric oxide: first in a new class of neurotransmitters","volume":"257","author":"Snyder","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.107046_bb0355","first-page":"15","article-title":"The alteration of intrinsic excitability and synaptic transmission in lumbar spinal motor neurons and interneurons of severe spinal muscular atrophy mice","volume":"13","author":"Sun","year":"2019"},{"key":"10.1016\/j.nbd.2025.107046_bb0360","first-page":"519","article-title":"Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy","volume":"73","author":"Tarabal","year":"2014"},{"key":"10.1016\/j.nbd.2025.107046_bb0365","first-page":"78","article-title":"Functional abnormalities of cerebellum and motor cortex in spinal muscular atrophy mice","volume":"452","author":"Tharaneetharan","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0370","first-page":"8691","article-title":"Disease mechanisms and therapeutic approaches in spinal muscular atrophy","volume":"35","author":"Tisdale","year":"2015"},{"key":"10.1016\/j.nbd.2025.107046_bb0375","first-page":"883","article-title":"Spinal muscular atrophy: a changing phenotype beyond the clinical trials","volume":"27","author":"Tizzano","year":"2017"},{"key":"10.1016\/j.nbd.2025.107046_bb0380","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/146608201316949415","article-title":"The role of nitric oxide in amyotrophic lateral sclerosis","volume":"2","author":"Urushitani","year":"2001","journal-title":"Amyotroph Lateral Scler. Other Motor Neuron Disord."},{"key":"10.1016\/j.nbd.2025.107046_bb0385","first-page":"1155","article-title":"SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy","volume":"6","author":"Valsecchi","year":"2023"},{"key":"10.1016\/j.nbd.2025.107046_bb0390","first-page":"1157","article-title":"L-arginine and nitric oxide in CNS function and neurodegenerative diseases","volume":"53","author":"Virarkar","year":"2013"},{"key":"10.1016\/j.nbd.2025.107046_bb0395","first-page":"131","article-title":"The relationship between body composition, fatty acid metabolism and diet in spinal muscular atrophy","volume":"11","author":"Watson","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0400","first-page":"365","article-title":"Arginine metabolism and the synthesis of nitric oxide in the nervous system","volume":"64","author":"Wiesinger","year":"2001"},{"key":"10.1016\/j.nbd.2025.107046_bb0405","first-page":"306","article-title":"Spinal muscular atrophy: in the challenge lies a solution","volume":"44","author":"Wirth","year":"2021"},{"key":"10.1016\/j.nbd.2025.107046_bb0410","first-page":"231","article-title":"Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next","volume":"21","author":"Wirth","year":"2020"},{"key":"10.1016\/j.nbd.2025.107046_bb0415","first-page":"4216","article-title":"SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy","volume":"19","author":"Wishart","year":"2010"},{"key":"10.1016\/j.nbd.2025.107046_bb0420","first-page":"22","article-title":"Mouse models of SMA show divergent patterns of neuronal vulnerability and resilience","volume":"12","author":"Woschitz","year":"2022"},{"key":"10.1016\/j.nbd.2025.107046_bb0425","first-page":"1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000"},{"key":"10.1016\/j.nbd.2025.107046_bb0430","first-page":"12","article-title":"Overturning the paradigm of spinal muscular atrophy as just a motor neuron disease","volume":"109","author":"Yeo","year":"2020"},{"key":"10.1016\/j.nbd.2025.107046_bb0435","first-page":"489","article-title":"A cross-sectional and longitudinal evaluation of serum creatinine as a biomarker in spinal muscular atrophy","volume":"19","author":"Zhao","year":"2024"},{"key":"10.1016\/j.nbd.2025.107046_bb0440","article-title":"Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defect","volume":"132","author":"Zhou","year":"2022"},{"key":"10.1016\/j.nbd.2025.107046_bb0445","first-page":"154","article-title":"Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study","volume":"50","author":"Zhuang","year":"2024"},{"key":"10.1016\/j.nbd.2025.107046_bb0450","first-page":"139","article-title":"Nitric oxide and angiogenesis","volume":"50","author":"Ziche","year":"2000"},{"key":"10.1016\/j.nbd.2025.107046_bb0455","first-page":"10878","article-title":"Mitochondrial dysfunction in spinal muscular atrophy","volume":"23","author":"Zilio","year":"2022"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:21:36Z","timestamp":1772878896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":91,"alternative-id":["S0969996125002621"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107046","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nusinersen corrects L-arginine deficiency in the cerebrospinal fluid of patients with severe spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107046"}}